Found 779 matching trials
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer PHASE2 Researchers conducting this study hope to learn about the safety and effect...
Show More Location
University of Chicago Comprehensive Cancer Center
Learn More & Join Trial
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer PHASE2 The primary objective of this study is to determine whether zoledronic acid...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness PHASE1 Frailty is one of the main reasons older adults lose independence. Frailty ...
Show More Status
Active Not Recruiting
Location
University of Maryland, Baltimore
Learn More & Join Trial
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC PHASE3 The purpose of this study is to determine if the addition of apalutamide to...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET PHASE2 This is a phase 2, open-label, randomized study of adjuvant treatment in su...
Show More Location
Dept of Surgical Sciences - Urology, Molinette Hospital, University of Torino
Learn More & Join Trial
First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors PHASE1 This study is an open-label, multicenter, first-in-human, Phase I, dose esc...
Show More Location
Breast Cancer Research Centre
Learn More & Join Trial
Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment NA Italian multicenter study, will enroll \~566 pts with oligometastatic hormo...
Show More Location
European Institute of Oncology
Learn More & Join Trial
An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment N/A In this observational study, participants receive darolutamide: a treatment...
Show More Learn More & Join Trial
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer NA RATIONALE: Studying samples of blood and tissue from patients with cancer i...
Show More Location
Cancer Research UK at Cambridge Research Institute
Learn More & Join Trial
Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer PHASE2 This phase II trial studies how well docetaxel or abiraterone acetate work ...
Show More Location
Huntsman Cancer Institute/University of Utah
Learn More & Join Trial